Cellexus Appoints Chief Scientific Officer
Cellexus Biosystems (Cambridgeshire, UK, www.cellexusbiosystems.com) has selected Julie Bick, MD, as its chief scientific officer.
Cellexus Biosystems (Cambridgeshire, UK, www.cellexusbiosystems.com) has selected Julie Bick, MD, as its chief scientific officer. Bick has the worldwide responsibility for leading the company’s research and customer support programs and will be based in the US from the company’s wholly owned subsidiary, Cellexus Biosystems, Inc. Bick is a biochemist with considerable expertise in cell culture and has worked in the areas of protein therapeutics, protein engineering, and assay platform development.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
